Literature DB >> 18267240

Olfaction in Parkinson's disease.

Richard L Doty1.   

Abstract

It has become increasingly apparent that Parkinson's disease (PD) can no longer be considered purely a motor disease, as numerous sensory alterations accompany this disorder either before or early in its clinical progression. Most notable among such disturbances are decrements in smell function. Such anomalies have been documented in approximately 90% of patients with early-stage sporadic PD and appear to progress little, if at all, with the development of the more classic PD-related motor symptoms. In this paper, I briefly review the nature of the olfactory dysfunction observed in PD and current theories as to its pathological basis.

Entities:  

Mesh:

Year:  2007        PMID: 18267240     DOI: 10.1016/S1353-8020(08)70006-3

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  24 in total

1.  Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease.

Authors:  Steven E Arnold; Edward B Lee; Paul J Moberg; Lauren Stutzbach; Hala Kazi; Li-Ying Han; Virginia M Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

2.  A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions.

Authors:  Sheila M Fleming; Caitlin K Mulligan; Franziska Richter; Farzad Mortazavi; Vincent Lemesre; Carmen Frias; Chunni Zhu; Alistair Stewart; Illana Gozes; Bruce Morimoto; Marie-Françoise Chesselet
Journal:  Mol Cell Neurosci       Date:  2010-12-27       Impact factor: 4.314

3.  Olfactory dysfunction and parasympathetic dysautonomia in Parkinson's disease.

Authors:  Peter Kang; John Kloke; Samay Jain
Journal:  Clin Auton Res       Date:  2012-08       Impact factor: 4.435

4.  Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson's disease.

Authors:  P Solla; C Masala; A Liscia; R Piras; T Ercoli; L Fadda; T Hummel; A Haenher; G Defazio
Journal:  J Neurol       Date:  2019-09-25       Impact factor: 4.849

Review 5.  A systematic review on olfaction in child and adolescent psychiatric disorders.

Authors:  Martin Schecklmann; Christina Schwenck; Regina Taurines; Christine Freitag; Andreas Warnke; Manfred Gerlach; Marcel Romanos
Journal:  J Neural Transm (Vienna)       Date:  2012-07-19       Impact factor: 3.575

6.  Inducible dopaminergic glutathione depletion in an α-synuclein transgenic mouse model results in age-related olfactory dysfunction.

Authors:  Y H Kim; S Lussier; A Rane; S W Choi; J K Andersen
Journal:  Neuroscience       Date:  2010-11-03       Impact factor: 3.590

7.  Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease.

Authors:  James F Morley; Daniel Weintraub; Eugenia Mamikonyan; Paul J Moberg; Andrew D Siderowf; John E Duda
Journal:  Mov Disord       Date:  2011-05-24       Impact factor: 10.338

8.  FMRI correlates of olfactory processing in typically-developing school-aged children.

Authors:  Natalia M Kleinhans; Melissa Reilly; Matthew Blake; Gabriella Greco; Julia Sweigert; Greg E Davis; Francisco Velasquez; Fredrick Reitz; Dennis Shusterman; Stephen R Dager
Journal:  Psychiatry Res Neuroimaging       Date:  2018-12-02       Impact factor: 2.376

Review 9.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

10.  Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation.

Authors:  Robert I Henkin; Samuel J Potolicchio; Lucien M Levy; Ramy Moharram; Irina Velicu; Brian M Martin
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.